Added to YB: 2021-06-30
Pitch date: 2021-06-30
CVM [bearish]
CEL-SCI Corporation
+97.58%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.
Market Cap
$16.7M
Pitch Price
$263.13
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.96
P/E
-0.45
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Cel-Sci CVM
A summary for this pitch has not been created yet.
Read full article (0 min)